COVID-19 mRNA vaccines may improve survival for advanced lung and skin cancer patients receiving immunotherapy

infosalus.com (Spanish)

COVID-19 mRNA vaccines may improve survival for advanced cancer patients receiving immunotherapy. Researchers found patients with advanced lung or skin cancer who received a COVID-19 mRNA vaccine lived significantly longer when treated with immunotherapy. This preliminary finding, presented at a European oncology congress, could lead to a universal cancer vaccine and revolutionize cancer care.


With a significance score of 5.1, this news ranks in the top 1.3% of today's 31990 analyzed articles.

Get summaries of news with significance over 5.5 (usually ~10 stories per week). Read by 10,000+ subscribers: